Cite
HARVARD Citation
Tameris, M. et al. (2015). A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants. Vaccine. 33 (25), pp. 2944-2954. [Online].